Filing Details

Accession Number:
0001209191-21-004769
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-01-21 21:00:12
Reporting Period:
2021-01-19
Accepted Time:
2021-01-21 21:00:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1478320 Adaptive Biotechnologies Corp ADPT Biological Products, (No Disgnostic Substances) (2836) 270907024
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1780790 Louise Nancy Hill C/O Adaptive Biotechnologies Corp.
Suite 200
Seattle WA 98102
Evp, Operations & Program Mana No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-01-19 2,000 $0.84 12,000 No 4 M Direct
Common Stock Disposition 2021-01-19 23,000 $4.07 35,000 No 4 M Direct
Common Stock Disposition 2021-01-19 25,000 $69.00 10,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2021-01-19 2,000 $0.00 2,000 $0.84
Common Stock Stock Option (Right to Buy) Disposition 2021-01-19 23,000 $0.00 23,000 $4.07
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2023-11-03 No 4 M Direct
27,000 2025-04-17 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 500 Indirect By Ryan Hill (son)
Common Stock 400 Indirect By Brandon Hill (son)
Common Stock 300 Indirect By Connor Hill (son)
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2020.
  2. The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.
  3. The option is fully vested and exercisable.